Plasma Receptor for Advanced Glycation End-products Predicts Duration of ICU Stay and Mechanical Ventilation in Patients After Lung Transplantation

This publication has 48 references indexed in Scilit:

• Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status
  PLOS ONE, 2012
• Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
  The Lancet Oncology, 2012
• A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
  Genome Research, 2011
• Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
  The Lancet Oncology, 2011
• The Genomics of Lung Adenocarcinoma: Opportunities for Targeted Therapies
  Genes & Cancer, 2010
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
  Nucleic Acids Research, 2010
• Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
  New England Journal of Medicine, 2009
• Somatic mutations affect key pathways in lung adenocarcinoma
  Nature, 2008
• The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
  Journal of Thoracic Oncology, 2008
• Association of Protein C and Type 1 Plasminogen Activator Inhibitor with Primary Graft Dysfunction
  American Journal of Respiratory and Critical Care Medicine, 2007